Kidney Transplant

Kidney transplant recipients may benefit from using metformin due to its correlation with reduced death-censored graft failure, according to data published in the American Journal of Kidney Diseases.

The number of discarded deceased donor kidneys increased in the United States between 2018 and 2022, according to data published in Kidney International Reports.

Using pre-transplant immunosuppression to treat kidney transplant recipients with glomerulonephritis correlates with an increased risk for developing malignancy after transplant, according to a retrospective study.

Heart-kidney transplantation relative to heart transplantation alone was associated with superior survival regardless of dialysis status and for patients with moderate kidney disease, according to a national transplant registry analysis.

Kidney transplant outcomes among undocumented immigrants in California are similar to that of U.S. residents, according to data published in JAMA Network Open.

Testing for coronary heart disease within 12 months before kidney transplantation did not correlate with a change in death or myocardial infarction within 30 days after the transplant, according to data published in JAMA Internal Medicine.

Governor Kathy Hochul of New York signed the New York State Living Donor Support Act to provide direct reimbursement up to $10,000 to living organ donors, according to an American Kidney Fund press release.

Prolonged cold ischemia time may not be a good enough reason to discard a kidney donation, according to a study published in Kidney Medicine.

The odds of undergoing a successful pancreas transplantation for people with diabetes have increased in recent years, but the number of adults undergoing the procedure is declining, according to a review article.

Patients with a kidney transplant who are younger than 65 years qualify for expanded immunosuppressive drug coverage starting Jan. 1, 2023.